×

Sign In

Search
Home

AbbVie to buy Landos to expand pipeline of immunity-related illnesses

By Thomson Reuters Mar 25, 2024 | 7:39 AM

(Reuters) – AbbVie said on Monday it would acquire drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses.

(Reporting by Leroy Leo in Bengaluru; Editing by Sriraj Kalluvila)

Russia's Lavrov says US-South Korea nuclear guideline adds concern, media reports

Olympics-Skateboarding-First day of skateboarding competition postponed amid bad weather

Nigeria courts convict 125 Boko Haram Islamist insurgents in mass trial

Israel tells Gazans to temporarily vacate southern Khan Younis areas

FSB foils militant attacks in southern Russia, RIA reports

Hungary to allow nuclear plant to exceed Danube water temperature limit

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2024. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.